Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 2,776 | 2,547 | 3,602 | 2,730 | 3,571 |
| Operating Income | -2,776 | -2,547 | -3,602 | -2,730 | -3,571 |
| Other Income | -4 | -2 | 0 | -16 | 0 |
| Pre-tax Income | -2,780 | -2,549 | -3,602 | -2,746 | -3,571 |
| Net Income Continuous | -2,780 | -2,549 | -3,602 | -2,746 | -3,571 |
| Net Income | $-2,780 | $-2,549 | $-3,602 | $-2,731 | $-3,576 |
| EPS Basic Total Ops | -10.25 | -13.27 | -28.35 | -21.60 | -28.26 |
| EPS Basic Continuous Ops | -10.26 | -13.27 | -28.39 | -21.68 | -28.22 |
| EPS Diluted Total Ops | -10.25 | -13.27 | -28.35 | -21.60 | -28.26 |
| EPS Diluted Continuous Ops | -10.26 | -13.27 | -28.39 | -21.68 | -28.22 |
| EBITDA(a) | $-2,761 | $-2,532 | $-3,586 | $-2,715 | $-3,556 |